Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ZYUS Life Sciences Corp V.ZYUS

Alternate Symbol(s):  ZLSCF

Healthcare
ZYUS Life Sciences Corporation is a Canada-based life sciences company. The Company is focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and exempt market therapeutics. Through clinical research, it is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product... see more

Recent & Breaking News (TSXV:ZYUS)

    ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

    Business Wire 3 days ago

    ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

    Business Wire February 1, 2024

    ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

    Business Wire January 9, 2024

    ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

    Business Wire December 5, 2023

    ZYUS Life Sciences Corporation Reports Q3 2023 Results

    Business Wire November 29, 2023

    ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

    Business Wire November 21, 2023

    ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

    Business Wire October 24, 2023

    ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

    Business Wire August 31, 2023

    ZYUS Life Sciences Corp. Closes the Market

    Canada NewsWire July 19, 2023

    ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

    Business Wire June 29, 2023